COO:NSD-The Cooper Companies, Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 78.7

Change

-0.81 (-1.02)%

Market Cap

USD 15.49B

Volume

2.26M

Analyst Target

USD 346.82
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia; and spherical lense, including lenses that correct near and farsightedness in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including paragard contraceptive intrauterine devices; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
ISRG Intuitive Surgical Inc

-14.42 (-2.99%)

USD 161.79B
HOLX Hologic Inc

-0.62 (-1.08%)

USD 13.84B
ALGN Align Technology Inc

+0.81 (+0.47%)

USD 11.30B
RGEN Repligen Corporation

+1.64 (+1.26%)

USD 7.49B
MMSI Merit Medical Systems Inc

-1.29 (-1.42%)

USD 6.12B
ICUI ICU Medical Inc

-1.95 (-1.41%)

USD 3.43B
XRAY Dentsply Sirona Inc

-0.01 (-0.08%)

USD 2.70B
LMAT LeMaitre Vascular Inc

-1.56 (-1.81%)

USD 1.93B
ATRC AtriCure Inc

-0.27 (-0.84%)

USD 1.70B
AZTA Azenta Inc

-0.22 (-0.87%)

USD 1.43B

ETFs Containing COO

GDOC Goldman Sachs ETF Trust 4.24 % 0.00 %

-0.47 (-1.56%)

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -14.39% 53% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -14.39% 51% F 49% F
Trailing 12 Months  
Capital Gain -12.59% 55% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -12.59% 55% F 45% F
Trailing 5 Years  
Capital Gain 7.04% 59% D- 48% F
Dividend Return 0.07% 25% F N/A F
Total Return 7.11% 59% D- 42% F
Average Annual (5 Year Horizon)  
Capital Gain 1.58% 57% F 47% F
Dividend Return 1.59% 57% F 42% F
Total Return 0.01% 20% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 24.99% 86% B+ 68% D+
Risk Adjusted Return 6.36% 60% D- 42% F
Market Capitalization 15.49B 97% N/A 95% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.